Synthetic sustained gene delivery systems

Current Topics in Medicinal Chemistry

Volumn 8, Issue 4, 2008, Pages 311-330

  Agarwal, Ankit ^a   Mallapraga, Surya K ^a  

^a Iowa State University of Science and Technology   (United States)

Author keywords

Controlled release; Gene delivery; Hydrogels; Microparticles; Nanoparticles; Plasmid DNA; Polymer; Scaffolds

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; ADENOVIRUS VECTOR; BASIC FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN; CHITOSAN; COLLAGEN; DENDRIMER; DNA VACCINE; DYSTROPHIN; GELATIN; HERPESVIRUS VECTOR; INTERLEUKIN 5; LIPOFECTAMINE; LIPOSOME; MATRIX METALLOPROTEINASE; METHACRYLIC ACID; MICROSPHERE; NAKED DNA; NANOPARTICLE; NANOSPHERE; PARVOVIRUS VECTOR; PLASMID DNA; POLYETHYLENEIMINE; POLYGLACTIN; POLYLYSINE; PROTEIN P53; RETROVIRUS VECTOR; SMALL INTERFERING RNA; UNINDEXED DRUG; VASCULOTROPIN; BIOMATERIAL; DNA; POLYMER;

ANTINEOPLASTIC ACTIVITY; BIODEGRADABILITY; BREAST CANCER; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; DIABETIC NEPHROPATHY; DNA IMMUNIZATION; DRUG EFFICACY; DRUG SAFETY; ENCAPSULATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROGEL; IMMUNOTHERAPY; LIPOSOMAL GENE DELIVERY SYSTEM; LOW DRUG DOSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; NUCLEIC ACID IMMOBILIZATION; REVIEW; SQUAMOUS CELL CARCINOMA; SUSTAINED DRUG RELEASE; TISSUE ENGINEERING; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRAL RESPIRATORY TRACT INFECTION; WOUND HEALING; ANIMAL; CHEMISTRY; GENE THERAPY; GENE TRANSFER; GENE VECTOR; POROSITY; SYNTHESIS; TISSUE SCAFFOLD;

ANIMALS; BIOCOMPATIBLE MATERIALS; DNA; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; HYDROGELS; MICROSPHERES; NANOSPHERES; POLYMERS; POROSITY; TISSUE SCAFFOLDS;

EID: 44249118350     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802608783790965     Document Type: Review

References (174)

1. Kay, M.A.; Liu, D.; Hoogerbrugge, P.M. Gene therapy. Proc. Natl. Acad. Sci. USA 1997, 94, 12744-12746.
2. Young, L.S.; Searle, P.F.; Onion, D. and Mautner, V. Viral gene therapy strategies: From basic science to clinical application. J. Pathol. 2006, 208, 299-318.
3. Verma, I.M. A Tumultuous Year for Gene Therapy. Mol. Ther. 2000, 2, 415-416.
4. Boyce, N. Trial halted after gene shows up in semen. Nature 2001, 414, 677.
5. Check, E. Gene therapy: A tragic setback. Nature 2002 420, 116-118.
6. El-Aneed, A. An overview of current delivery systems in cancer gene therapy. J. Control. Release 2004, 94, 1-14.
7. Henry, C.M. Gene delivery-without viruses. Chem. Eng. News 2001, 79, 35-41.
8. Richardson, T.P.; Peters, M.C.; Ennett, A.B. and Mooney, D.J. Polymeric system for dual growth factor delivery. Nat. Biotech. 2001, 19, 1029-1034.
9. Bonadio, J.; Smiley, E.; Patil, P. and Goldstein, S. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat Med. 1999, 5, 753-759
10. Ohno, T.; Gordon, D.; San, H.; Pompili, V.J.; Imperiale, M.J.; Nabel, G.J. and Nabel, E.G. Gene therapy for vascular smooth muscle cell proliferation after uterial injury. Science 1994, 265, 781-784.
11. Lee, W.S.; Jain, M.K.; Arkonac, B.M.; Zhang, D.; Shaw, S.Y.; Kashiki, S.; Maemura, K.; Lee, S.L.; Holtenberg, N.K. and Lee et, a. Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circ. Res. 1998, 82, 845-851.
12. Glover, D.J.; Lipps, H.J. and Jans, D.A. Towards safe, non-viral therapeutic gene expression in humans. Nat. Rev. Genet. 2005, 6, 299-310.
13. Herweijer, H. and Wolff, J.A. Progress and prospects: Naked DNA gene transfer and therapy. Gene Ther. 2003, 10, 453-458.
14. Tripathy, S.K.; Svensson, E.C.; Black, H.B.; Goldwasser, E.; Margalith, M.; Hobart, P.M. and Leiden, J.M. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. Natl. Acad. Sci. USA 1996, 93, 10876-10880.
15. Tokui, M.; Takei, I.; Tashiro, F.; Shimada, A.; Kasuga, A.; Ishii, M.; Ishii, T.; Takatsu, K.; Saruta, T. and Miyazaki, J.-I. Intramuscular injection of expression plasmid DNA is an effective means of long-term systemic delivery of interleukin-5. Biochem Biophys. Res. Commun. 1997, 233, 527-531.
16. Laham, R.J.; Chronos, N.A.; Pike, M.; Leimbach, M.E.; Udelson, J.E.; Pearlman, J.D.; Pettigrew, R.I.; Whitehouse, M.J.; Yoshizawa, C. and Simons, M. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a Phase I open-label dose escalation study. J. Am. Coll. Cardiol. 2000, 36, 2132-2139.
17. Lathi, K.G.; Vale, P.R.; Losordo, D.W.; Cespedes, R.M.; Symes, J.F.; Esakof, D.D.; Maysky, M. and Isner, J.M. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: Anesthetic management and results. Anesth. Analg. 2001, 92, 19-25.
18. Braun, S.; Thioudellet, C.; Rodriguez, P.; Ali-Hadji, D.; Perraud, F.; Accart, N.; Balloul, J.-M.; Halluard, C.; Acres, B.; Cavallini, B. and Pavirani, A. Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice. Gene Ther. 2000, 7, 1447-1457.
19. Ledley, F.D.. Pharmaceutical Approach to Somatic Gene Therapy. Pharm. Res. 1996, V13, 1595-1614.
20. Klinman, D.M.; Yamshchikov, G. and Ishigatsubo, Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 1997, 158, 3635-3639.
21. Yew, N.S.; Zhao, H.; Wu, I.-H.; Song, A.; Tousignant, J.D.; Przybylska, M. and Cheng, S.H. Reduced Inflammatory Response to Plasmid DNA Vectors by Elimination and Inhibition of Immunostimulatory CpG Motifs. Mol. Ther. 2000, 1, 255-262.
22. Yew, N.S.; Zhao, H.; Przybylska, M.; Wu, L-H.; Tousignant, J.D.; Scheule, R.K. and Cheng, S.H. CpG-Depleted Plasmid DNA Vectors with Enhanced Safety and Long-Term Gene Expression in vivo, Mol. Ther. 2002, 5, 731-738.
23. Roy, K.; Wang, D.; Hedley, M.L.; and Barman, S.P. Gene delivery with in-situ crosslinking polymer networks generates long-term systemic protein expression. Mol. Ther. 2003, 7, 401-408
24. Thomas, M. and Klibanov, A.M. Non-viral gene therapy: Polycation mediated DNA delivery. Appl. Microbiol. Biotechnol. 2003, 62, 27-34.
25. Pack, D.W.; Hoffman, A.S.; Pun, S. and Stayton, P.S. Design and development of polymers for gene delivery. Nat. Rev. Drug Discov. 2005, 4, 581-593.
26. Simoes, S.; Filipe, A.; Faneca, H.; Mano, M.; Penacho, N.; Duzgunes, N. and Pedroso de Lima, M. Cationic liposomes for gene delivery. Expert. Opin. Drug. Deliv. 2005, 2, 237-254.
27. Putnam, D. Polymers for gene delivery across length scales. Nat. Mater. 2006, 5, 439-451.
28. Karmali, P.P. and Chaudhuri, A. Cationic liposomes as non-viral carriers of gene medicines: Resolved issues open questions, and future promises. Med. Res. Rev. 2007, 27, 696-722.
29. Boulaiz, H.; Marchal, J.A.; Prilos, J.; Melguizo, C. and Aránega, A. Non-viral and viral vectors for gene therapy. Cell. Mol. Biol. 2005, 51, 3-22.
30. Beer, S.J.; Matthews, C.B.; Stein, C.S.; Ross, B.D.; Hilfinger, J.M. and Davidson, B.L. Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo. Gene Ther. 1998, 5, 740-746.
31. Sailaja, G.; HogenEsch, H.; North, A.; Hays, J. and Mittal, S.K. Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response. Gene Ther. 2002, 9, 1722-1729.
32. Matthews, C.B.; Jenkins, G.; Hilfinger, J.M. and Davidson, B.L. Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres. Gene Ther. 1999, 6, 1558-1564.
33. Panyam, J. and Labhasetwar, V. lglod4adable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug. Del. Rev. 2003, 55, 329-347.
34. Davda, J. and Labhasetwar, V. Characterization of nanoparticle uptake by endothelial cells. Int. J. Pharm. 2002, 233, 51-59.
35. Panyam, J.; Zhou, W.-Z.; Prabba, S.; Sahoo, S.K. and Labhasetwar, V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB J. 2002, 16, 1217-1226.
36. Desai, M.P.; Labhasetwar, V.; Walter, E.; Levy, R.J. and Amidon, G.L. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 1997, 14, 1568-1573.
37. Desai, M.P.; Labhasetwar, V.; Amidon, G.L. and Levy, R.J. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size. Pharm. Res. 1996, 13, 1838-1845.
38. Sandor, M.; Mehta, S.; Harris, I.; Thanos, C.; Weston, P.; Marshall, J. and Mathiowitz, E. Transfection of HEK cells via DNA-loaded PLGA and P(FASA) nanospheres. J. Drug. Target. 2002, 10, 497-506.
39. Cohen, H.; Levy, R.J.; Gao, J.; Fishbein, I.; Kousaev, V.; Sosnowski, S.; Slomkowski, S.and Golomb, G. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther. 2000, 7, 1896-1905.
40. Prabha, S. and Labasetwar, V. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Molecular Pharmaceutics 2004, 1, 211-219.
41. Truong-Le, V.L.; August, J.T. and Leong, K.W. Controlled gene delivery by DNA-gelatin nanospheres. Hum. Gene. Ther. 1998, 9, 1709-1717.
42. Leong, K.W.; Mao, H.-Q.; Truong-Le, V.L.; Roy, K.; Walsh, S.M.; August, J.T. DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Control. Release 1998, 53, 183-193.
43. Labhasetwar, V.; Bonadio, J.; Goldstein, S.A. and Levy, R.J. Gene transfection using biodegradable nanospheres: Results in tissue culture and a rat osteotomy model. Colloids Surf. B. Biointerfaces 1999, 16, 281-290.
44. Guzman, L.A.; Labhasetwar, V.; Song, C.; Jang, Y.; Lincoff, A.M.; Levy, R. and Topol, E.J. Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty. Circulation 1996, 94, 1441-1448.
45. Prabha, S.; Zhou, W.-Z.; Panyam, J. and Labhasetwar, V. Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int. J. Pharm. 2002, 244, 105-115
46. Labbasetwar, V.; Bonadio, J.; Goldstein, S.; Chen, W. and Levy, R.J. A DNA controlled-release coating for gene transfer: Transfection in skeletal and cardiac muscle. J. Pharm. Sci. 1998, 87, 1347-1350.
47. Thanou, M.; Verhoef, J.C. and Junginger, H.E. Chitosan and its derivatives as intestinal absorption enhancers. Adv. Drug Del. Rev. 2001, 50, S91-S101.
48. Mohapatra, S.S. Mucosal gene expression vaccine: A novel vaccine strategy for respiratory syncytial virus. Pediatr. Infect. Dis. J. 2003, 22, Supplement:S100-S104.
49. Kaul, G. and Amiji, M. Tumor-Targeted Gene Delivery Using Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles: In Vitro and in Vivo Studies. Pharm. Res. 2005, V22, 951-961.
50. Kommareddy, S. and Amiji, M. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice. J. Pharm. Sci. 2006, 9999, n/a.
51. Wang, J.; Zhang, P.-C.; Mao, H.-Q. and Leong, K.W. Enhanced gene expression in mouse muscle by sustained release of plasmid DNA using PPE-EA as a carrier. Gene Ther. 2002, 9, 1254-1261.
52. Ribeiro, S.; Hussain, N. and Florence, A.T. Release of DNA from dendriplexes encapsulated in PLGA nanoparticles. Int. J. Pharm. 2005, 298, 354-360.
53. Kushibiki, T.; Watsumoto, K.; Nakamura, T. and Tabata, Y. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized. gelatin. Gene Ther. 2004 11, 1205-1214.
54. Kushibiki, T.; Matsumoto, K.; Nakamura, T. and Tabata, Y. Suppression of the Progress of Disseminated Pancreatic Cancer Cells by NK4 Plasmid DNA Released from Cationized Gelatin Microspheres. Pharm. Res. 2004 V21, 1109-1118.
55. Mathiowitz, E.; Jacob, J.S.; Jong, Y.S.; Carino, G.P.; Chickering, D.E.; Chaturvedi, P.; Santos, C.A.; Vijayaraghavan, K.; Montgomery, S.; Bassett, M. and Morrell, C. Biologically erodable microspheres as potential oral drug delivery systems. Nature 1997, 386, 410-414.
56. Jones, DR.; Corris, S.; McDonald, S.; Clegg, J.C.S. and Farrar, G.H. Poly(lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine 1997, 15, 814-817.
57. Aggarwal, N.; HogenEsch, H.; Guo, P.; North, A.; Suckow, M.; Mittal, S.K. Biodegradable alginate microspheres as a delivery system for naked DNA. Can. J. Vet. Res. 1999, 63, 148-152.
58. Hedley, M.L.; Curley, J. and Urban, R. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat. Med. 1998, 4, 365-368.
59. Ruedl, C. and Wolf, H. Features of oral immunization. Int. Arch. Allergy Appl. Immunol. 1995, 108, 334-339.
60. Elson, C.O. In defense of mucosal surfaces: Regulation and manipulation of the mucosal immune system. Adv. Exp. Med. Biol. 1997, 412, 373-385.
61. Chickering, D.E. and Mathiowitz, E. Bioadhesive microspheres: I. A novel electrobalance-based method to study adhesive interactions between individual microspheres and intestinal mucosa. J. Control. Release 1995, 34, 251-262.
62. Khan, A.; Benboubetra, M.; Sayyed, P.Z; Ng, K.W.; Fox, S.; Beck, G.; Benter, I.F. and Akhtar, S. Sustained Polymeric Delivery of Gene Silencing Antisense ODNs, siRNA, DNAzymes and Ribozymes: In Vitro and In Vivo Studies. J. Drug Target 2004, 12, 393-404
63. Thomasin, C.; Corradin, G.; Men, Y.; Merkle, H.P. and Gander, B. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/ poly(lactide-co-glycolide) microspheres: Importance of polymer degradation and antigen release for immune response. J. Control. Release 1996, 41, 131-145.
64. Gander, B.; Wehrli, E.; Alder, R. and Merkle, H.P. Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection. J. Microencapsul 1995, 12, 83-97.
65. Tinsley-Bown, A.M.; Fretwell, R.; Dowsett, A.B.; Davis, S.L. and G.H. Farrar Formulation of poly(-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. J. Control. Release 2000, 66, 229-241.
66. Luo, D.; Woodrow-Mumford, K.; Belcheva, N. and Saltzman, W.M. Controlled DNA Delivery Systems. Pharm. Res. 1999, V16, 1300-1308.
67. C. S. Lengsfeld, T.J.A. Shear-induced degradation of plasmid DNA. J. Pharm. Sci. 2002, 91, 1581-1589.
68. Jones, D.H.; Partidos, C.D.; Steward, M.W. and Farrar, G.H. Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines. Behring. Inst. Mitt. 1997, 220-228.
69. Ando, S.; Putnam, D.; Pack, D.W. and Langer, R. PLGA microspheres containing plasmid DNA: Preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J. Pharm. Sci. 1999, 88, 126-130.
70. Wang, D.; Robinson, D.R.; Kwon, G.S. and Samuel, J. Encapsulation of plasmid DNA in biodegradable poly(,-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J. Control. Release 1999, 57, 9-18.
71. Jang, J.-H. and Shea, L.D. Intramuscular delivery of DNA releasing microspheres: Microsphere properties and transgene expression. J. Control. Release 2006, 112, 120-128.
72. Walter, E.; Dreher, D.; Kok, M.; Thiele, L.; Kiama, S.G.; Gehr, P. and Merkle, H.P. Hydrophilic poly(-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. J. Control. Release 2001, 76, 149-168.
73. Walter, E.; Moelling, K.; Pavlovic, J. and Merkle, H.P. Microencapsulation of DNA using poly(-lactide-co-glycolide): Stability issues and release characteristics. J. Control. Release 1999, 61, 361-374.
74. Diez, S. and Tros de Ilarduya, C. Versatility of biodegradable poly(d,l-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Eur. J. Pharm Biopharm. 2006, 63, 188-197.
75. Butler, S.M.; Tracy, M.A. and Tilton, R.D. Adsorption of serum albumin to thin films of poly(lactide-co-glycolide). J. Control. Release 1999, 58, 335-347.
76. Young, S.; Wong, M.; Tabata, Y. and Mikos, A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release 2005, 109, 256-274.
77. Aoyama, T.; Yamamoto, S.; Kanematsu, A.; Ogawa, O. and Tabata, Y. Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice. Tissue Eng. 2003, 9, 1289-1299.
78. Matsumoto, G.; Kushibiki, T.; Kinoshita, Y.; Lee, U.; Omi, Y.; Kubota, E. and Tabata, Y. Cationized. gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma. Cancer Sci. 2006, 97, 313-321.
79. Akbuga, J.; Aral, C.; Ozbas-Turan, S.; Kabasakal, L. and Keyer-Uysal, M. Transfection efficiency of chitosan microspheres: Effect of DNA topology. S.T.P. Pharma Sci. 2003, 13, 99-103.
80. Ozbas-Turan, S.; Aral, C.; Kabasakal, L.; Keyer-Uysal, M. and Akbuga, J. Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle. J. Pharm. Pharm. Sci. 2003, 6, 27-32.
81. Janes, K.A.; Calvo, P. and Alonso, M.J. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Del. Rev. 2001, 47, 83-97.
82. Aral, C.; Ozbas-Turan, S.; Kabasakal, L.; Keyer-Uysal, M. and Akbuga, J. Studies of effective factors of plasmid DNA-loaded chitosan microspheres I. Plasmid size, chitosan concentration and plasmid addition techniques. S.T.P. Pharma Sci. 2000, 10, 83-88.
83. Berthold, A.; Cremer, K. and Kreuter, J. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J. Control. Release 1996, 39, 17-25.
84. Akbuga, J.; Ozbas-Turan, S. and Erdogan, N. Plasmid-DNA loaded chitosan microspheres for in vitro IL-2 expression. Eur. J. Pharm. Biopharm. 2004, 58, 501-507.
85. Yun, Y.H.; Goetz, D.J.; Yellen, P. and Chen, W. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 2004, 25, 147-157.
86. Lameiro, M.H.; Malpique, R.; Silva, A.C.; Alves, P.M. and Melo, E. Encapsulation of adenoviral vectors into chitosan-bile salt microparticles for mucosal vaccination. J. Biotechnol. 2006, 126, 152-162.
87. Shiba, H.; Okamoto, T.; Futagawa, Y.; Misawa, T.; Yanaga, K.; Ohashi, T. and Eto, Y. Adenovirus Vector-Mediated Gene Transfer Using Degradable Starch Microspheres for Hepatocellular Carcinoma in Rats. J. Surg. Res. 2006, 133, 193-196.
88. Ismail, F.A.; Napaporn, J.; Hughes, J.A. and Brazeau, G.A. In situ gel formulations for delivery: Release and myotoxicity studies. Pharm. Dev. Technol. 2000, 5, 391-397.
89. Ruel-Gariepy, E. and Leroux, J.-C. In situ-forming hydrogels-review of temperature-sensitive systems. Eur. J. Pharm. Biopharm. 2004, 58, 409-426.
90. Srividya, B.; Cardoza, R.M. and Amin, P.D. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J. Control. Release 2001, 73, 205-211.
91. Cappello, J.; Crissman, J.W.; Crissman, M.; Ferrari, F.A.; Textor, G.; Wallis, O.; Whitledge, J.R.; Zhou, X.; Burman, D.; Aukerman, L. and Stedronsky, E.R. In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs. J. Control. Release 1998, 53, 105-117.
92. Megeed, Z.; Cappello, J. and Ghandehari, H. Controlled Release of Plasmid DNA from a Genetically Engineered Silk-Elastinlike Hydrogel. Pharm Res. 2002, V19, 954-959.
93. Jeong, B.; Kim, S.W. and Bae, Y.H. Thermosensitive sol-gel reversible hydrogels. Adv. Drug. Del. Rev. 2002, 54, 37-51
94. Kissel, T.; Li, Y. and Unger, F. ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for protein. Adv. Drug Del. Rev. 2002, 54, 99-134
95. Strappe, P.M.; Hampton, D.W.; Cachon-Gonzalez, B.; Fawcett, J.W. and Lever, A. Delivery of a lentiviral vector in a Pluronic F127 gel to cells of the central nervous system. Eur. J. Pharm. Biopharm. 2005, 61, 126-133.
96. Feldman, L.J.; Pastore, C.J.; Aubailly, N.; Kearney, M.; Chen, D.; Perricaudet, M.; Steg, P.G. and Isner, J.M. Improved efficiency of arterial gene transfer by use of poloxamer 407 as a vehicle for adenoviral vectors. Gene Ther. 1997, 4, 189-198
97. Siow, R.C.M.; Mallawaarachchi, Weissberg, P.L. Migration of adventitial myofibroblasts following vascular balloon injury: Insights from in vivo gene transfer to rat carotid arteries. Cardiovasc. Res. 2003, 59, 212-221.
98. Chun, K.W.; Lee, J.B.; Kim, S.H. and Park, T.G. Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels. Biomaterials 2005, 26, 3319-3326.
99. Xiong, X.Y.; Tam, K.C. and Gan, L.H. Polymeric Nanostructures for Drug Delivery Applications Based on Pluronic Copolymer Systems. J. Nanosci. Nanotechnol. 2006, 113, 164-172.
100. Choi, H.-G.; Jung, J.-H.; Ryu, J.-M.; Yoon, S.-J.; Oh, Y.-K. and Kim, C.-K. Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository. Int. J. Pharm. 1998, 165, 33-44.
101. Park, J.-S.; Oh, Y.-K.; Yoon, H.; Kim, J.M. and Kim, C.-K. In situ gelling and mucoadhesive polymer vehicles for controlled intranasal delivery of plasmid DNA. J. Biomed. Mater. Res. A. 2002, 59, 144-151.
102. Determan, M.D.; Cox, J.P.; Seifert, S.; Thiyigarajan, P. and Mallapragada, S.K. Synthesis and characterization of temperature and pH responsive pentablock copolymers. Polymer 2005, 46, 6933-6946.
103. Agarwal, A.; Unfer, R.C. and Mallapragada, S.K. Novel cationic pentablock copolymers as non-viral vectors for gene therapy. J. Control. Release 2005, 103, 245-258.
104. Determan, M.D.; Cox, J.P. and Mallapragada, S.K. Drug release from pH-responsive thermogelling pentablock copolymers. J. Biomed. Mater. Res. A 2007, 81(A), 326-333.
105. Agarwal, A.; Unfer, R.C. and Mallapragada, S.K. Multi-functional amphiphilic copolymers for efficient gene transfection and sustained gene delivery. Biomaterials 2007, In review.
106. Agarwal, A.; Vilensky, R.; Stockdale, A.; Unfer, R.C.; Talmon, Y. and Mallapragada, S.K. Colloidally stable novel copolymeric system for gene delivery in complete growth media. J. Control. Release 2007, 121, 28-37.
107. Agarwal, A.; Unfer, R.C. and Mallapragada, S.K. Investigation of in vitro biocompatibility of novel pentablock copolymers for gene delivery. J. Biomed. Mater. Res. A 2007, 81A, 24-39.
108. Lee, P.-Y.; Li, Z. and Huang, L. Thermosensitive Hydrogel as a TGF-β1 Gene Delivery Vehicle Enhances Diabetic Wound Healing. Pharm. Res. 2003, 20, 1995-2000.
109. Meilander-Lin, N.J.; Cheung, P.J.; Wilson, D.L. and Bellamkonda, R.V. Sustained in Vivo Gene Delivery from Agarose Hydrogel Prolongs Nonviral Gene Expression in Skin. Tissue Eng. 2005, 11, 546-555.
110. Toussaint, J.F.; Dubois, A.; Dispas, M.; Paquet, D.; Letellier, C. and Kerkhofs, P. Delivery of DNA vaccines by agarose hydrogel implants facilitates genetic immunization in cattle. Vaccine 2007, 25, 1167-1174.
111. Fukunaka, Y.; Iwanaga, K.; Morimoto, K.; Kakemi, M. and Tabata, Y. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J. Control. Release 2002, 80, 333-343.
112. Kushibiki, T.; Tomoshige, R.; Fukunaka, Y.; Kakemi, M. and Tabata, Y. In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents. J. Control. Release 2003, 90, 207-216.
113. Kasper, F.K.; Seidlits, S.K.; Tang, A.; Crowther, R.S.; Carney, D.H.; Barry, M.A. and Mikos, A.G. In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels. J. Control. Release 2005, 104, 521-539.
114. Kasper, F.K.; Kushibiki, T.; Kimura, Y.; Mikos, A.G. and Tabata, Y. In vivo release of plasmid DNA from composites of oligo(poly(ethylene glycol)fumarate) and cationized gelatin microspheres. J. Control. Release 2005, 107, 547-561.
115. Krsko, P.; Saaem, L; Clancy, R.; Geller, H.; Soteropoulos, P. and Libera,M. E-beam-patterned hydrogels to control nanoscale surface bioactivity. Proc. SPIE-Int. Soc. Opt. Eng. 2005.
116. Quick, D.J. and Anseth, K.S. DNA delivery from photocrosslinked PEG hydrogels: Encapsulation efficiency, release profiles, and DNA quality. J. Control. Release 2004, 96, 341-351.
117. Quick, D.J. and Anseth, K.S. Gene Deliveryy in Tissue Engineering: A Photopolymer Platform to Coencapsulate Cells and Plasmid DNA. Pharm. Res. 2003, V20, 1730-1737.
118. Nakayama, Y.; Ji-Youn, K.; Nishi, S.; Ueno, H. and Matsuda, T. Development of high -performance stent: Gelatinous photogel-coated stent that permits drug delivery and gene transfer. J. Biomed. Mater. Res. A 2001, 57, 559-566.
119. Quick, D.J.; Macdonald, K.K. and Anseth, K.S. Delivering DNA from photocrosslinked, surface eroding polyanhydrides. J. Control Release 2004, 97, 333-343.
120. Fang, J.; Zhu, Y.-Y.; Smiley, E.; Bonadio, J.; Rouleau, J.P.; Goldstein, S.A.; McCauley, L.K.; Davidson, B.L. and Roessler, B.J. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Natl. Acad Sci. USA 1996, 93, 5753-5758.
121. Chen, H.; Frankenburg, E.P.; Goldstein, S.A. and McCauley, L.K. Combination of local and systemic parathyroid hormone enhances bone regeneration. Clin. Orthop. Relat. Res. 2003, 291-302.
122. Pascher, A.; Palmer, G.D.; Steinert, A.; Oligino, T.; Gauze, E.; Gauze, J.-N.; Betz, O.; Spector, M.; Robbins, P.D.; Evans, C.H. and Ghivizzani, S.C. Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther. 2004 11, 133-141.
123. Berry, M.; Gonzalez, A.M.; Clarke, W.; Greenlees, L.; Barrett, L; Tsang, W.; Seymour, L.; Bonadio, J. and Logan, A.; Baird, A. Sustained effects of gene-activated matrices after CNS injury. Mol. Cell. Neurosci. 2001, 17, 706-716.
124. Tyrone, J.W.; Mogford, J.E.; Chandler, L.A.; Ma, C.; Xia, Y.; Pierce, G.F. and Mustoe, T.A. Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model. J. Surg. Res. 2000, 93, 230-23.
125. Chandler, L.A.; Ma, C.; Gonzalez, A.M.; Doukas, J.; Nguyen, T.; Pierce, G.F. and, Phillips, M.L. Matrix-enabled gene transfer for cutaneous wound repair. Wound Repair Regen. 2000, 8, 473-479.
126. Pakkanen, T.M.; Laitinen, M.; Hippeläinen, M.; Hiltunen, M.O.; Alhava, E. and Ylä-Herttuala, S. Periadventitial lacZ gene transfer to pig carotid arteries using a biodegradable collagen collar or a wrap of collagen sheet with adenoviruses and plasmid-liposome complexes. J. Gene Med. 2000, 2, 52-60.
127. Christman, K.L.; Fang, Q.; Yee, M.S.; Johnson, K.R.; Sievers, R.E. and Lee, R.J. Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials 2005, 26, 1139-1144.
128. Scherer, F.; Schillinger, U.; Putz, U.; Stemberger, A. and Plank, C. Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo. J. Gene Med. 2002, 4, 634-643
129. Ochiya, T.; Takahama, Y.; Nagahara, S.; Sumita, Y.; Hisada, A.; Itoh, H.; Nagai, Y. and Terada, M. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: The Minipellet. Nat. Med. 1999, 5, 707-710.
130. Guo, T.; Zhao, J.; Chang, J.; Ding, Z.; Hong, H.; Chen, J. and Zhang, J. Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-[beta]1 for chondrocytes proliferation. Biomaterials 2006, 27, 1095-1103.
131. Samuel, R.E.; Lee, C.R.; Ghivizzani, S.C.; Evans, C.H.; Yannas, I.V.; Olsen, B.R.; Spector, M. Delivery of plasmid DNA to articular chondrocytes via novel collagen-glycosaminoglycan matrices. Hum. Gene. Ther. 2002 13, 791-802.
132. Kim, A.; Checkla, D.M.; Dehazya, P. and Chen, W. Characterization of DNA-hyaluronan matrix for sustained gene transfer. J. Control. Release 2003, 90, 81-95.
133. Kim, A.P.; Yellen, P.; Yun, Y.H.; Azeloglu, E. and Chen, W. Delivery of a vector encoding mouse hyaluronan synthase 2 via a crosslinked hyaluronan film. Biomaterials 2005, 26, 1585-1593
134. Siemens, D.R.; Austin, J.C.; Hedican, S.P.; tartaglia, J. and Ratliff, T.L. Viral Vector Delivery in Solid-State Vehicles: Gene Expression in a Murine Prostate Cancer Model. J. Natl. Cancer Inst. 2000, 92, 403-412.
135. Chen, T.; Embree, H.D.; Brown, E.M.; Taylor, M.M. and Payne, G.F. Enzyme-catalyzed gel formation of gelatin and chitosan: Potential for in situ applications. Biomaterials 2003, 24, 2831-2841.
136. Rubin, A.L.; Stenzel, K.H.; Miyata, T.; White, M.J. and Dunn, M. Collagen as a Vehicle for Drug Delivery: Preliminary Report. J. Clin. Pharmacol. New Drugs 1973, 13, 309-312.
137. Sano, A.; Maeda, M.; Nagahara, S.; Ochiya, T.; Honma, K.; Itoh, H.; Miyata, T. and Fujioka, K. Atelocollagen for protein and gene delivery. Adv. Drug. Del. Rev. 2003, 55, 1651-1677.
138. Luu, Y.K.; Kim, K.; Hsiao, B.S.; Chu, B. and Hadjiargyrou, M. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J. Control. Release 2003, 89, 341-353.
139. Jang, J.-H. and Shea, L.D. Controllable delivery of non-viral DNA from porous scaffolds. J. Control. Release 2003, 86, 157-168.
140. Huang, Y.-C.; Riddle, K.; Rice, K.G. and Mooney, D.J. Long-Term In Vivo Gene Expression via Delivery of PEI DNA Condensates from Porous Polymer Scaffolds. Hum. Gene. Ther. 2005, 16, 609-617.
141. Huang, Y.-C.; Kaigler, D.; Rice, K.G.; Krebsbach, P.H. and Mooney, D.J. Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell-Driven Bone Regeneration. J. Bone Miner. Res. 2005, 20, 848-857.
142. Liang, D.; Luu, Y.K.; Kim, K.; Hsiao, B.S.; Hadjiargyrou, M. and Chu, B. In vitro non-viral gene delivery with nanofibrous scaffolds. Nucleic Acids Res. 2005, 33, e170-.
143. Moriah Nof, L.D.S. Drug-releasing scaffolds fabricated from drug-loaded microspheres. J. Biomed. Mater. Res. A 2002, 59, 349-356.
144. Shea, L.; Smiley, E.; Bonadio, J. and Mooney, D.J. DNA delivery from polymer matrices for tissue engineering. Nat. Biotech. 1999, 17, 551-554.
145. Shen, H.; Goldberg, E. and Saltzman, W.M. Gene expression and mucosal immune responses after vaginal DNA immunization in mice using a controlled delivery matrix. J. Control. Release 2003, 86, 339-348.
146. Livingston, B.; Lu, S.; Robinson, H.L. and Anderson, D.J. The induction of mucosal immunity in the female genital tract using gene-gun technology. Part 1: Antigen expression. Ann. N. Y. Acad. Sci. 1995, 772, 265-267.
147. Livingston, J.B.; Lu, S.; Robinson, H. and Anderson, D.J. Immunization of the female genital tract with a DNA-based vaccine. Infect. Immun. 1998, 66, 322-329.
148. Radomsky, M.L.; Whaley, K.J.; Cone, R.A. and Saltzman, W.M. Controlled vaginal delivery of antibodies in the mouse. Biol. Reprod. 1992, 47, 133-140.
149. Bielinska, A.U.; Yen, A.; Wu, H.L; Zahos, K.M.; Sun, R.; Weiner, N.D.; Baker Jr., J.R. and Roessler, B.J. Application of membrane-based dendrimer/DNA complexes for solid phase tmnsfection in vitro and in vivo. Biomaterials 2000, 21, 877-887.
150. Kofron, M.D. and Laurencin, C.T. Development of a calcium phosphate co-precipitate/poly(lactide-co- glycolide) DNA delivery system: Release kinetics and cellular transfection studies. Biomaterials 2004, 25, 2637-2643.
151. Segura, T.; Anderson, B.C.; Chung, P.H.; Webber, R.E.; Shull, K.R. and Shea, L.D. Crosslinked hyaluronic acid hydrogels: A strategy to functionalize and pattern. Biomaterials 2004, 26, 359-371.
152. Segura, T.; Volk, M.J. and Shea, L.D. Substrate-mediated DNA delivery: Role of the cationic polymer structure and extent of modification. J. Control. Release 2003, 93, 69-84.
153. Segura, T. and Shea, L.D. Surface-tethered DNA complexes for enhanced gene delivery. Bioconjug. Chem. 2002, 13, 621-629
154. Abrahams, J.M.; Song, C.; DeFelice, S.; Grady, M.S.; Diamond, S.L. and Levy, R.J. Endovascular Microcoil Gene Delivery Using Immobilized Anti-adenovirus Antibody for Vector Tethering. Stroke 2002, 33, 1376-1382.
155. Klugherz, B.D.; Song, C.; Defelice, S.; Cui, X.; Lu, Z.; Connolly, J.; Travis Hinson, J.; Wilensky, R.L. and Levy, R.J. Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus. Hum. Gene. Ther. 2002, 13, 443-454.
156. Pandori, M.W.; Hobson, D.A. and Sano, T, Adenovirus-Microbead Conjugates Possess Enhanced Infectivity: A New Strategy for Localized Gene Delivery. Virology 2002, 299, 204-212.
157. Parrott, M.B. and Barry, M.A. Metabolic Biotinylation of Secreted and Cell Surface Proteins from Mammalian Cells. Biochem. Biophys. Res. Commum. 2001, 281, 993-1000.
158. Parrot, M.B. and Barry, M.A. Metabolic Biotinylation of Recombinant Proteins in Mammalian Cells and in Mice. Mol. Ther. 2000, 1, 96-104.
159. Stachelek, S.L.; Song, C.; Alferiev, I.; Defelice, S.; Cui, X.; Connolly, J.M.; Bianco, R.W. and Levy, R.J. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants. Gene Ther. 2004, 11, 15-24.
160. Cavanagh, H.M.A.; Dingwall, D.; Steel, J.; Benson, J. and Burton, M. Cell contact dependent extended release of adenovirus by microparticles in vitro. J. Virol Methods 2001, 95, 57-64.
161. Mah, C.; Fraites, J., Thomas, J.; Zolotukhin, I.; Song, S.; Flotte, T.R.; Dobson, J.; Batich, C. and Byrne, B.J. Improved Method of Recombinant - AAV2 Delivery for Systemic Targeted Gene Theraphy. Mol. Ther. 2002, 6, 106-112.
162. Dropulic, B. and June, C.H. Gene-Based Immunotherapy for Human Immunodeficiency Virus Infection and Acquired Immunodefficiency Syndrome. Hum Gene. Ther. 2006, 17, 577-588.
163. Mason, D.J.; Genevar, P.G.; Itaka, K. and Alini, M. Glutamate signalling and its potential application to tissue engineering of bone. Eur. Cell. Mater. 2004, 7, 12-26.
164. Geiger, F.; Bertram, H.; Berger, I.; Lorenz, H.; Wall, O.; Eckhardt, C. and Simank, H.-G.; Richter, W. Vascular Endothelial Growth Factor Gene-Activated Matrix (VEGF165-GAM) Enhances Osteogenesis and Angiogenesis in Large Segmental Bone Defects. J. Bone Miner. Res. 2005, 20, 2028-2035.
165. Huang, Y.-C.; Simmons, C.; Kaigler, D.; Rice, K.G. and Mooney, D.J. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Ther. 2005, 12, 418-426.
166. Murray, M. and Fischer, I. Transplantation and gene therapy: Combined approaches for repair of spinal cord injury. Neuroscientist 2001, 7, 28-41.
167. Ozawa, C. R.; Banfi, A.; Glazer, N.L.; Thurston, G.; Springer, M.L.; Kraft, P.E.; McDonald, D.M. and Blau, H.M. Micro-environmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J. Clin. Invest. 2004, 113, 516-527.
168. Rebar, E.J.; Huang, Y.; Hickey, R.; Nath, A.K; Meoli, D.; Nath, S.; Chen, B.; Xu, L; Liang, Y.; Jamieson, A.C.; Zhang, L.; Spratt, S.K,; Case, C.C.; Wolffe, A. and Giordano, F.J. Induction of angiogenesis in a mouse model using engineered transcription factors. Nat. Med. 2002 8, 1427-1432.
169. Murphy, W.L. and Mooney, D.J. Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. J. Periodontal Res. 1999, 34, 413-419.
170. Kong, H.J.; Liu, J.; Riddle, K.; Matsumoto, T.; Leach, K. and Mooney, D.J. Non-viral gene delivery regulated by stiffness of cell adhesion substrates. Nat. Mater. 2005, 4, 460-464.
171. Saltzman, W.M. and Olbricht, W.L. Building drug delivery into tissue engineering. Nat. Rev. Drug Discov. 2002, 1, 177-186.
172. Salvay, D.M. and Shea, L.D. Inductive tissue engineering with protein and DNA-releasing scaffolds. Mol. BioSys. 2006, 2, 36-48.
173. Storrie, H. and Mooney, D.J. Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv. Drug. Del. Rev. 2006, 58, 500-514.
174. Jang, J.-H.; Houchin, T.L. and Shea, L.D. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev. Med. Devices 2004, 1, 127-138.